Pharmaceuticals and their metabolites in the marine environment: Sources,analytical methods and occurrence

The occurrence of pharmaceuticals in the environmental waters is a global concern. There is little research conducted on the monitoring of pharmaceuticals in the marine environment. In this article, the occurrence of pharmaceuticals and their metabolites in the coastal waters as well as associated risks related to their uptake by marine organisms are critically reviewed. The literature showed antibiotics as the most plentiful pharmaceuticals in the marine environment. Other therapeutic classes of pharmaceuticals appeared prominently in the marine environment are non-steroidal anti-inflammatory drugs and β-blockers, while gemfibrozil and carbamazepine were singled-out as the most studied lipid regulator and antiepileptic, respectively. Some pharmaceuticals have been found present in the marine organisms that are regarded as important food sources for humans. We reviewed the negative effects associated with the presence of pharmaceuticals in the marine environment. This article is concluded by deliberating on the possible future studies in this research niche area.     

Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications

The presence of pharmaceuticals in the aquatic environment is an ever-increasing issue of concern as they are specifically designed to target specific metabolic and molecular pathways in organisms, and they may have the potential for unintended effects on nontarget species. Information on the presence of pharmaceuticals in biota is still scarce, but the scientific literature on the subject has established the possibility of bioaccumulation in exposed aquatic organisms through other environmental compartments. However, few studies have correlated both bioaccumulation of pharmaceutical compounds and the consequent effects. Analytical methodology to detect pharmaceuticals at trace quantities in biota has advanced significantly in the last few years. Nonetheless, there are still unresolved analytical challenges associated with the complexity of biological matrices, which require exhaustive extraction and purification steps, and highly sensitive and selective detection techniques. This review presents the trends in the analysis of pharmaceuticals in aquatic organisms in the last decade, recent data about the occurrence of these compounds in natural biota, and the environmental implications that chronic exposure could have on aquatic wildlife.     

Studies of human and veterinary drugs' fate in environmental solid samples--analytical problems

The improvement of medical care worldwide is one of the reasons for the increasing production of pharmaceutical products. Human medicines are affordable to a greater proportion of the world's population. But a significant amount of used pharmaceuticals can create problems--accessibility to high volume production pharmaceuticals contributes to an increased contamination in the environment and the possibility of adverse effects on humans and animals. Many of these substances and their metabolites end up in the soil, sediments, and sludge. Knowledge regarding the environmental occurrence of pharmaceutical products is increasing, but information in the peer-reviewed literature regarding the fate and effects of most pharmaceuticals is limited. One of the reasons for this lack of data is that, until now, there have been few analytical methods capable of detecting these compounds at the low levels, which might be expected in the environment. This review article covers recent developments in the analysis of pharmaceuticals in environmental solid matrices (including soil, sediments, and sludge). We will report applications of different solid sample extraction methods, and current advances in liquid chromatography coupled with mass spectrometry for detection and identification of selected drugs in sludge, soils, manure, and sediments.     

Determination of Pharmaceutical Drug Residues on Suspended Particulate Material in Surface Water

Recent studies have demonstrated the presence of traces of various pharmaceutical drugs in the aquatic environment. Comprehensive data about the distribution of such compounds between the aqueous phase and suspended particulate material are still missing. In the present article a gas chromatographic method with mass spectrometric detection is presented which allows the determination of the particle-bound fraction of some pharmaceuticals commonly found in surface water. Determination limits are between 2 and 12 ng/g particles. Results from surface water samples indicate the possibility that less hydrophilic pharmaceuticals like mefenamic acid are present as suspended particulate material, although the amounts are small in comparison with the concentrations found in aqueous phase. Additional work will be necessary to evaluate the full importance of particle-bound pharmaceuticals with respect to transportation in the environment.     

Fate and occurrence of X-ray contrast media in the environment

Interest in the presence of pharmaceuticals in the environment has recently increased. Despite continuous research efforts there is still a large gap in our knowledge of their fate and effects on the ecosystem. This review covers current information on the occurrence of iodinated X-ray contrast media (ICM) in the environment and developments in the analysis of these highly polar organic micropollutants in aqueous environmental samples. Findings from monitoring surveys conducted on wastewater-treatment plants (WWTP), surface waters, and drinking waters are compiled, and strategies for removal of the compounds in WWTP and waterworks using advanced treatment are reported. Characteristics and advantages of different compound-specific or element-specific mass spectrometric techniques used to monitor ICM in the environment are compared, and applications in elucidation of the structures of biotransformation products, generated in laboratory-scale experiments that simulate sewage treatment or river water/sediment systems, are described.     

Weniger Umweltbelastung durch Umweltzeichen: Arznei‐ und Körperpflegemittel

Many pharmaceuticals and personal care products are released into the water compartment after use. It was shown previously that some compounds or their metabolites are stable in the environment and some have or may have effects on the environment. The Eco Label Scheme could enhance the use of environmentally safe products and thus foster the precautionary principle. We developed Basic Criteria for an Eco Label for Shampoos, Shower gels and Bath Foams.     

The removal of pharmaceutical pollutants from aqueous solution by Agro-waste

Pharmaceuticals are a unique class of emerging contaminants owing to their intrinsic ability to induce physiological effects on man and animals at low concentrations. Pharmaceuticals are released into the environment via diverse routes; human and animal wastes are the major sources. The persistence and mode of action of pharmaceuticals in the environment make them a major concern. Among methods available for wastewater treatment, the adsorption technique is found to be effective and easy to operate. The expensive nature of commercial activated carbons, however, created a limitation to the adsorption technique; hence the exploration for low-cost and sustainable adsorbents for the removal of different categories of water contaminants. Agricultural wastes offer such advantages as low-cost, abundance and eco-friendly materials in adsorbent preparation. Herein presented are the category and classes of pharmaceuticals cum the risks associated with pharmaceuticals released into the environment. The chemistry of activated carbon/agro wastes viz-a-viz suitability and potency in adsorption of different pharmaceutical waste removal were reviewed; the benefits associated with agricultural wastes usage in pharmaceutical removal have also been presented. Various challenges, gaps cum research prospects in the current field of discussion are herein presented. This work will serve as a tool for public education and enlightenment, help environmentalists make plans for envisaged threats and serve as a guide for policy makers.     

Analysis of 70 Environmental Protection Agency priority pharmaceuticals in water by EPA Method 1694

The U.S. Environmental Protection Agency (EPA) Method 1694 for the determination of pharmaceuticals in water recently brought a new challenge for treatment utilities, where pharmaceuticals have been reported in the drinking water of 41-million Americans. This proposed methodology, designed to address this important issue, consists of solid-phase extraction (SPE) followed by liquid chromatography–mass spectrometry (LC/MS–MS) using triple quadrupole. Under the guidelines of Method 1694, a multi-residue method was developed, validated, and applied to wastewater, surface water and drinking water samples for the analysis of 70 pharmaceuticals. Four distinct chromatographic gradients and LC conditions were used according to the polarity and extraction of the different pharmaceuticals. Positive and negative ion electrospray were used with two MRM transitions (a quantifier and a qualifier ion for each compound), which adds extra confirmation not included in the original Method 1694. Finally, we verify, for the first time, EPA Method 1694 on water samples collected in several locations in Colorado, where positive identifications for several pharmaceuticals were found. This study is a valuable indicator of the potential of LC/MS–MS for routine quantitative multi-residue analysis of pharmaceuticals in drinking water and wastewater samples and will make monitoring studies much easier to develop for water utilities across the US, who are currently seeking guidance on analytical methods for pharmaceuticals in their water supplies.     

Mass spectrometry for identifying pharmaceutical biotransformation products in the environment

Many classes of pharmaceuticals have been detected in wastewaters and surface waters around Europe, but little is known about their occurrence, fate and potential harmful effects on the environment, and that makes them an important group among those compounds considered to be new emerging contaminants. To understand the cycling of pharmaceuticals and their metabolites, it is essential to possess qualitative and quantitative information on their presence in the environment. This review covers the current status and future prospects of advanced hyphenated mass spectrometric (MS) techniques (gas chromatography-MS (GC-MS) and liquid chromatography-MS (LC-MS)) in elucidating the structures of trace contaminants, namely pharmaceutical biodegradation products in complex environmental matrices. The article is oriented towards technique and method and discusses capabilities, potential and limitations of different GC and LC mass analyzers (quadrupole, ion trap, time-of-flight and hybrid techniques) in dealing with analytical challenges of complex matrices and trace contaminants. We also give practical examples of their applications. The main scope of this article is to support and to facilitate the on-going research on pharmaceutical biodegradation products in environmental samples.     

Multi-residue analysis of pharmaceutical compounds in aqueous samples

Pharmaceutical compounds are nowadays an emerging group of organic pollutants in aquatic systems. Several methodologies have already been published to measure these pollutants in the environment, showing the difficulties to take into account the various compounds belonging to numerous therapeutical and chemical groups. In order to develop environmental monitoring, there is a need for a less costly and time-consuming multi-component procedure. The work presented here deals with the development of an extraction procedure which enables the measurement of a wide spectrum of pharmaceuticals at trace levels (ng 1(-1)) with quite simple equipment (i.e. GC-MS with single quadruple as analyzer). The analyzed compounds comprise anti-inflammatories, antidepressants and hypolipidic drugs. The reliability and sensitivity have been tested on 18 different compounds (7 basic compounds and 11 acidic drugs) extracted simultaneously and analyzed by GC-MS. The optimized procedure has been successfully applied to the analysis of wastewaters, surface waters and drinking waters from the following areas: first the Cortiou rocky inlet, in the Mediterranean Sea (South coast of France), highly impacted by the Marseilles wastewater treatment plant effluent and secondly the Hérault watershed by studying drinking water, surface water and wastewater. In both cases, the level of pharmaceuticals was totally unknown. Results obtained have demonstrated the suitability of the method for multi-residue analysis of different types of water matrices.     

Screening for pharmaceutical transformation products formed in river sediment by combining ultrahigh performance liquid chromatography/high resolution mass spectrometry with a rapid data-processing method

While the occurrence of pharmaceuticals in the aquatic environment has been extensively investigated, their environmental fate is less thoroughly explored. Scarce information on their transformation pathways and transformation products (TPs) limits conventional target analytical approaches. In this study, samples from water/sediment tests were analyzed by ultrahigh performance liquid chromatography interfaced with quadrupole time-of-flight mass spectrometry (UHPLC/QToF-MS). A data processing method based on peak detection, time-trend filtration and structure assignment was established to provide an efficient way for identifying the key TPs in terms of persistence; all software used for the individual steps of this method is freely available. The accurate mass and meaningful time-trends were major contributors in facilitating the isolation of plausible TP peaks. In total, 16 TPs from 9 parent pharmaceuticals were identified. Eleven out of the 16 TPs were confirmed by corresponding reference standards; no standards were available for the remaining TPs. For additional 6 potential TPs, a molecular formula was suggested but no additional structural information could be generated. Among the TPs identified in the water/sediment tests, carbamazepine-10,11-epoxide (parent: carbamazepine), saluamine (parent: furosemide), chlorothiazide and 4-amino-6-chloro-1,3-benzenedisulfonamide (parent of both: hydrochlorothiazide), and 1-naphthol (parent: propranolol) accumulated over the entire incubation period of 35 days.     

Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments

Pharmaceutical residues in the environment, and their potential toxic effects, have been recognized as one of the emerging research area in the environmental chemistry. The increasing attention, on pharmaceutical residues as potential pollutants, is due that they often have similar physico-chemical behaviour than other harmful xenobiotics which are persistent or produce adverse effects. In addition, by contrast with regulated pollutants, which often have longer environmental half-lives, its continuous introduction in the environment may make them “pseudopersistents”.Pharmaceutical residues and/or their metabolites are usually detected in the environment at trace levels, but, even that, low concentration levels (ng/L or μg/L) can induce to toxic effects. In particular, this is the case of antibiotics and steroids that cause resistance in natural bacterial populations or endocrine disruption effects.In this study, an overview of the environmental occurrence and ecological risk assessment of pharmaceutical residues is presented from literature data. Risk Quotient method (RQ) was applied as a novel approach to estimate the environmental risk of pharmaceuticals that are most frequently detected in wastewater effluents, surface waters and sediments.     

Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research

Pollution from pharmaceuticals in the aquatic environment is now recognized as an environmental concern in many countries. This has led to the creation of an extensive area of research, including among others: their chemical identification and quantification; elucidation of transformation pathways when present in wastewater-treatment plants or in environmental matrices; assessment of their potential biological effects; and development and application of advanced treatment processes for their removal and/or mineralization. Pharmaceuticals are a unique category of pollutants, because of their special characteristics, and their behavior and fate cannot be simulated with other chemical organic contaminants. Over the last decade the scientific community has embraced research in this specific field and the outcome has been immense. This was facilitated by advances in chromatographic techniques and relevant biological assays. Despite this, a number of unanswered questions exist and still there is much room for development and work towards a more solid understanding of the actual consequences of the release of pharmaceuticals in the environment. This review tries to present part of the knowledge that is currently available with regard to the occurrence of pharmaceutical residues in aquatic matrices, the progress made during the last several years on identification of such compounds down to trace levels, and of new, previously unidentified, pharmaceuticals such as illicit drugs, metabolites, and photo-products. It also tries to discuss the main recent findings in respect of the capacity of various treatment technologies to remove these contaminants and to highlight some of the adverse effects that may be related to their ubiquitous existence. Finally, socioeconomic measures that may be able to hinder the introduction of such compounds into the environment are briefly discussed.     

Rapid analysis of iodinated X-ray contrast media in secondary and tertiary treated wastewater by direct injection liquid chromatography-tandem mass spectrometry

The iodinated X-ray contrast media are the most widely administered intravascular pharmaceuticals and are known to persist in the aquatic environment. A rapid method using direct injection liquid chromatography-tandem mass spectrometry (DI-LC-MS/MS) has been developed to measure eight ICM. These include iopamidol, iothalamic acid, diatrizoic acid, iohexol, iomeprol, iopromide, plus both ioxaglic acid and iodipamide, which have not previously reported in the literature. The LC-MS/MS fragmentation patterns obtained for each of the compounds are discussed and the fragments lost for each transition are identified. Matrix effects in post-RO water, MQ water, tap water and secondary effluent have also been investigated. The DI-LC-MS/MS method was validated on both secondary and tertiary treated wastewater, and applied to samples from an advanced activated sludge wastewater treatment plant (WWTP) and a water recycling facility using microfiltration (MF) and reverse osmosis (RO) in Perth, Western Australia. As well as providing information of the efficacy for RO to remove specific ICM, these results also represent the first values of ICM published in the literature for Australia.     

Current trends in the use of zero-valent iron (Fe0) for degradation of pharmaceuticals present in different water matrices

Zero-valent iron (Fe⁰) has recently been proposed as a potential candidate for the degradation of pharmaceuticals, because Fe⁰ can release dissolved iron species, activate molecular oxygen, and react with oxidant species. Additionally, due to its small particle size and large surface area, this catalyst can provide better degradation results, compared to traditional processes. This work focuses on the elimination of pharmaceuticals present in different water matrices, considering the potential harm that these substances can cause in the environment. The mechanisms of pharmaceutical removal using Fe⁰ particles include reduction, adsorption, precipitation, and oxidation processes. Most studies have focused on oxidation processes in the presence of Fe⁰ and radicals derived from oxidants such as hydrogen peroxide (H₂O₂), ozone (O₃), peroxysulfate (SO₅²⁻), peroxodisulfate (S₂O₈²⁻), and oxygen (O₂). Most of the results have shown that high percentages of pharmaceuticals can be removed, degraded, and mineralized. The mechanisms of oxidation and the parameters that influence the degradation of pharmaceuticals, as well as the possible degradation pathways, are discussed here. This review provides information on trends of different processes that use Fe⁰, considering aspects such as particle size, type of matrix, the pharmaceuticals studied, and the results obtained that can improve understanding of new advances in the field of advanced oxidation processes (AOPs) for the degradation and elimination of pharmaceuticals.     

Evaluation of pharmaceutical activities of G-protein coupled receptor targeted pharmaceuticals in Chinese wastewater effluent

The occurrence of biologically active pharmaceuticals in aquatic environments raised the potential risks to aquatic species. Among these marketed biological active pharmaceuticals, it has been estimated that 40% of them target G-protein-coupled receptors (GPCRs). We have illustrated pharmaceutical activities of GPCR targeted pharmaceuticals in English and Japanese wastewater by the in vitro transforming growth factor-α (TGFα) shedding assay. However, as the most important producer and consumer of pharmaceuticals, the occurrence of GPCR targeted pharmaceuticals in China had remained unclear. In this study, we investigated the pharmaceutical activities of GPCR targeted pharmaceuticals in secondary effluents of Chinese wastewater treatment plants. We discovered antagonistic activities against angiotensin (AT1) receptor at up to 7.2 × 102 ng-valsartan-equivalent quantity/L in Chinese wastewater for the first time as well as agonistic activities against dopamine (D2) receptor. Furthermore, in parallel with the assay, we determined concentrations of GPCR targeted pharmaceuticals in target wastewater by liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS). Through the comparison of predicted antagonistic activities calculated by concentrations and potency values from the assay, we found that the measured antagonistic activities against AT1 receptor from the assay were higher than the predicted AT1 activities from valsartan, irbesartan, and losartan, indicating the potential existence of other unknown AT1 antagonists in wastewater.     

Occurrence of environmentally relevant pharmaceuticals in Italian drinking water treatment plants

The occurrence and seasonal distribution of 14 pharmaceutical substances of different classes were investigated in two drinking water treatment plants (DWTPs) supplied by the two main Italian rivers, the Po and the Adige (Northern Italy). The therapeutic categories of the selected pharmaceuticals included anti-inflammatory drugs, β-blockers, lipid regulators, diuretics, anti-epileptics, antibiotics and a steroidal hormone. The named compounds were assessed in samples collected from the river water inlet and after each purification stage (sand filtration, ozone treatment, granular active carbon (GAC)). Six of the 14 selected pharmaceuticals were found in all analysed samples, with concentration levels ranging from 1?ng?l^?1 for atorvastatin to 69?ng?l^?1 for atenolol in the drinking water produced. The granular active carbon stage resulted the most efficient in eliminating the examined chemicals from the water (removal range: 12–95%, average: 68%), while the sand filtration stage resulted the least effective treatment (removal range: 4–37%, average: 13%). The observed differences between winter and summer conditions, in terms of residual concentrations and number of detected analytes, seemed to depend mainly on the quality of the river water supplies. To the best of our knowledge, these are the first reported data on the presence of pharmaceuticals in drinking water obtained from the water treatment of these two rivers.     

Multi‐residue analysis of 44 pharmaceutical compounds in environmental water samples by solid‐phase extraction coupled to liquid chromatography‐tandem mass spectrometry

A solid‐phase extraction combined with a liquid chromatography‐tandem mass spectrometry analysis has been developed and validated for the simultaneous determination of 44 pharmaceuticals belonging to different therapeutic classes (i.e., antibiotics, anti‐inflammatories, cardiovascular agents, hormones, neuroleptics, and anxiolytics) in water samples. The sample preparation was optimized by studying target compounds retrieval after the following processes: i) water filtration, ii) solid phase extraction using Waters Oasis HLB cartridges at various pH, and iii) several evaporation techniques. The method was then validated by the analysis of spiked estuarine waters and wastewaters before and after treatment. Analytical performances were evaluated in terms of linearity, accuracy, precision, detection, and quantification limits. Recoveries of the pharmaceuticals were acceptable, instrumental detection limits varied between 0.001 and 25 pg injected and method quantification limits ranged from 0.01 to 30.3 ng/L. The precision of the method, calculated as relative standard deviation, ranged from 0.3 to 49.4%. This procedure has been successfully applied to the determination of the target analytes in estuarine waters and wastewaters. Eight of these 44 pharmaceuticals were detected in estuarine water, while 26 of them were detected in wastewater effluent. As expected, the highest values of occurrence and concentration were found in wastewater influent.     

Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry

The occurrence, fate, and effects of phenols with endocrine-disrupting properties as well as some pharmaceuticals and personal-care products in the environment have frequently been discussed in recent literature. In many cases, these compounds were determined by using individual methods which can be time-consuming if results for multiple parameters are required. Using a solid-phase extraction procedure with an anion exchanger in this work, we have developed and optimized a multi-residue method for the extraction of 21 phenols and acids in sewage influent and effluent. The phenols and acids were then selectively eluted in separate fractions and were converted into pentafluoropropionyl (PFP) and tert-butyldimethylsilyl (TBDMS) derivatives, respectively, for gas chromatography-mass spectrometric (GC/MS) determination. When applied to the sewage samples under study, the results for nonylphenol, bisphenol A (BPA), triclosan (TCS), 17ss-estradiol (E2), estrone (E1), salicylic acid, ibuprofen, naproxen, diclofenac, and a few other acidic drugs were consistent with those determined previously by individual methods. Using the same procedure, we also report, for the first time, the occurrence of 2-phenylphenol and parabens in those sewage samples.     

LC-MS analysis in the aquatic environment and in water treatment technology – a critical review

Environmental contaminants of recent concern are pharmaceuticals, estrogens and other endocrine disrupting chemicals (EDC) such as degradation products of surfactants, algal and cyanobacterial toxins, disinfection by-products (DBPs) and metalloids. In addition, pesticides (especially their transformation products), microorganisms, and humic substances (HS), in their function as vehicles for contaminants and as precursors for by-products in water treatment, traditionally play an important role. The present status of the application of LC-MS techniques for these water constituents are discussed and examples of application are given. Solid-phase extraction with various non-selective materials in combination with liquid chromatography (LC) on reversed-phase columns have been the most widely used methods for sample preconcentration and separation for different compound classes like pesticides, pharmaceuticals or estrogens. Electrospray ionization (ESI) and atmospheric pressure ionization (APCI) are the most frequently used ionization techniques for polar and ionic compounds, as well as for less polar non-ionic ones. The facilities of LC-MS have been successfully demonstrated for different compound classes. Polar compounds from pharmaceuticals used as betablockers, iodinated X-ray contrast media, or estrogens have been determined without derivatization down to ultratrace concentrations. LC-MS can be viewed as a prerequisite for the determination of algal and cyanobacterial toxins and the homologues and oligomers of alkylphenol ethoxylates and their metabolites. Tandem mass spectrometric techniques and the use of diagnostic ions reveal their usefulness for compound-class specific screening and unknown identification, and are also valid for the analysis of pesticides and especially for their transformation products. Structural information has been gained by the application of LC-MS methods to organometallic species. New insights into the structural variety of humic substances have been made possible by FT-ICR-MS due to its ultrahigh mass resolution. Finally, exciting possibilities for rapid detection and identification of microorganisms have been made possible by MALDI and LC-MS methods.